Literature DB >> 30956199

Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents.

Osama Abu-Shawer1, Tariq Bushnaq1, Mohammad Abu-Shawer2.   

Abstract

After several years of discouraging results, immunotherapy finally becomes a powerful, clinically valid and approved treatment for numerous types of cancer. Immunotherapy involves treatment approaches that work in various ways; some boost the body's immune system while others help guide and direct the immune cells to attack cancer cells specifically. In this review article, we summarize the current cancer immunotherapy strategies; immune checkpoint blockade, adoptive cellular therapy, cancer vaccines, oncolytic viruses, and the monoclonal antibodies and discuss the recent progress and future trends of the combination therapies.

Entities:  

Mesh:

Year:  2019        PMID: 30956199

Source DB:  PubMed          Journal:  Gulf J Oncolog        ISSN: 2078-2101


  2 in total

1.  The Predictive Value of Peripheral Immune Cell Counts for the Presence of Brain Metastases in Stage IV Non-Small-Cell Lung Cancer (NSCLC).

Authors:  I Abuelbeh; O Abu-Shawer; M Abu-Shawer; M Alkderat; M Safi; A Alwazani; A Alkhatib; B Abu-Hussain; M Aladawi; S Ismail; T Altamimi; Taher Abu Hejleh
Journal:  Avicenna J Med       Date:  2022-07-03

2.  The clinical potential of circulating immune cell counts in primary gastric lymphoma.

Authors:  Ayman Haimour; Osama Abu-Shawer; Mohammad Abu-Shawer; Ali Al-Taji; Tamer Altamimi; Razan Mansour; Justin Z Amarin; Hala Sultan; Maysa Al-Hussaini
Journal:  J Gastrointest Oncol       Date:  2021-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.